🇺🇸 Summit Therapeutics Inc.SMMT

Company Update Form 8-K 28-09-2026 21:39:22 EDT

Subject: 8-K Items 1.01, 3.02, 5.03, 8.01, 9.01

Overview: AstraZeneca will make a $2.0 billion strategic equity investment in Summit Therapeutics and enter a clinical trial collaboration to evaluate ivonescimab.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest